News
PPBT
3.590
-0.83%
-0.030
Weekly Report: what happened at PPBT last week (0106-0110)?
Weekly Report · 3d ago
Purple Biotech Expands ATM Offering by $1.33 Million
TipRanks · 01/06 22:37
Weekly Report: what happened at PPBT last week (1230-0103)?
Weekly Report · 01/06 09:44
Weekly Report: what happened at PPBT last week (1223-1227)?
Weekly Report · 12/30/2024 09:42
Weekly Report: what happened at PPBT last week (1216-1220)?
Weekly Report · 12/23/2024 09:44
Weekly Report: what happened at PPBT last week (1209-1213)?
Weekly Report · 12/16/2024 09:45
Weekly Report: what happened at PPBT last week (1202-1206)?
Weekly Report · 12/09/2024 09:43
Purple Biotech Advances Oncology Drugs with New Funding
TipRanks · 12/06/2024 12:58
Purple Biotech Ltd. Closes $2.8 Million Registered Direct Offering of American Depositary Shares
Barchart · 12/05/2024 16:32
Purple Biotech Secures $2.8 Million for Oncology Advancements
TipRanks · 12/05/2024 12:47
Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares
Barchart · 12/05/2024 06:13
News Movers: Yesterday’s Hottest News That Could Move the Needle Today
Barchart · 12/05/2024 01:38
Purple Biotech Signs Securities Purchase Agreement
TipRanks · 12/04/2024 16:58
Purple Biotech Secures $2.8 Million Through ADS Offering
TipRanks · 12/03/2024 21:36
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 12/03/2024 21:05
Purple Biotech Ltd. Announces $2.8 Million Registered Direct Offering of American Depositary Shares
Barchart · 12/03/2024 17:36
Why Purple Biotech (PPBT) Stock Is Getting Hammered
Benzinga · 12/03/2024 14:30
Purple Biotech shares fall on $2.8M direct offering of ADS
Seeking Alpha · 12/03/2024 14:02
Purple Biotech to sell 472,668 ADSs at $6.00 in registered direct offering
TipRanks · 12/03/2024 13:25
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
Barchart · 12/03/2024 07:23
More
Webull provides a variety of real-time PPBT stock news. You can receive the latest news about Purple Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.